Melek Cihanbeylerden

7PUBLICATIONS
24CO-AUTHORS
Pharmaceutical delivery technologiesAboriginal and Torres Strait Islander and disabilityDisease surveillanceAutonomic nervous systemRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 14, 2026
Rapid Drug Desensitization to Platinum-based Chemotherapy Agents: A Single-center Experience.

Hazal Kayıkçı, Ebru Damadoğlu, Melek Cihanbeylerden

|Nov 03, 2025
Turkish language validity and reliability of the severe asthma Questionnaire (SAQ).

Bilun Gemicioglu, Gulfem Celik, Ebru Damadoglu

|Feb 11, 2025
Evaluation of Risk Factors Causing Diagnostic Delay in Non-steroidal Anti-inflammatory Drug-exacerbated Respiratory Disease.

Melek Cihanbeylerden, Hazal Kayıkçı, Çise Tüccar

|Mar 27, 2023
Comparison of the clinical outcomes of patients with NSAID-exacerbated respiratory disease receiving aspirin or biologicals.

Gülseren Tuncay, Ebru Damadoglu, Melek Cihanbeylerden

|Aug 01, 2022
Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.

Ozge Can Bostan, Emine Duran, Gulseren Tuncay

Pageof 2

Frequent Collaborators

7 joint publications

Ebru Damadoglu

4 joint publications

Gul Karakaya

4 joint publications

Ali Fuat Kalyoncu

4 joint publications

Hazal Kayıkcı